Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells
about
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family FlaviviridaeHepatitis G virusCharacterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptorAn 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cellsCharacterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell BindingConserved Determinants for Membrane Association of Nonstructural Protein 5A from Hepatitis C Virus and Related VirusesCharacterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV ReplicationBioinformatic and Physical Characterizations of Genome-Scale Ordered RNA Structure in Mammalian RNA VirusesGBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapyProposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family.Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitroPrevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, BrazilGBV-C infection and risk of NHL among U.S. adults.Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individualsGB virus type C E2 protein inhibits human immunodeficiency virus type 1 Gag assembly by downregulating human ADP-ribosylation factor 1.Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood RecipientsGB virus type C: a beneficial infection?GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expressionHepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivoGB virus C: the good boy virus?GB virus type C interactions with HIV: the role of envelope glycoproteins.GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolatesViruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targetingDeep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.HIV-GB virus C co-infection: an overview.Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection.Role of GB virus C in modulating HIV diseaseTropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.Detection of GB virus C genomic sequence in the cerebrospinal fluid of a HIV-infected patient in China: a case report and literature review.Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.Recombination among GB virus C (GBV-C) isolates in the United States.Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania.Analysis of GB virus C infection among HIV-HCV coinfected patients.Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results.
P2860
Q24609524-41C14BF6-5CD4-427E-B276-90FE52658151Q24658258-7D9279C2-54B0-4B58-891A-4B81F8A58C38Q27469307-35C61450-3FAB-43B4-BF61-ADBD55CBF9A2Q27477568-71F8A9F5-F890-4600-8C85-C7C19B8DAAD2Q27477720-44304956-7112-414A-B505-14F81F1701A6Q27478371-8238184F-589B-46D6-8F2C-EEC9D699CFF1Q27486387-10F06015-BF86-41A3-8422-0A704DF3CC8BQ27487338-0614BC39-C23C-4893-8186-A54A2E7172F5Q27489561-0AEF1902-A4AB-499B-B93F-659E5AD71BEFQ31134123-E20BD757-2712-4DE9-8A52-93270431AA16Q33635101-F59FF35D-29D9-4BA2-9F5E-F979E902AEF2Q33869199-138880A2-D058-495F-9615-1F21EF240226Q34287698-925DC77E-8811-42D8-86BC-4C8AA383CB4AQ34496833-17D5FECC-2ADF-46BC-8BBE-F1DBAB818E86Q34500494-BC5667B1-5E62-4506-9041-9892E1305884Q34674878-E25CE6A4-7C7F-45AA-8A19-28B8524B2B3FQ35077776-B8769855-760E-439C-A3FD-874B8EA50B7DQ35784618-2E8CCFE3-F35C-4199-A33D-C13B20BFE5E4Q35886281-562F5B28-5C34-45E9-96A3-C7E121ECAF9EQ36154171-C077C144-7C5B-4D06-9A07-ECE1BD1FBFB3Q36290103-9B2C9203-3E99-499D-B596-7EE8746E3BD4Q36336499-CACEE251-3FFC-4C17-B63A-B0E8244F5460Q36528539-0EC763ED-ACBF-49BA-969C-58B1CE9DA0F8Q36530370-3F96A353-DBA6-4ECC-B1B1-22B4E818D6FEQ36570711-D84B00CE-D5EC-4DA0-A8DC-1EA90E1B7733Q36598453-A245FB19-3FC4-457D-A7B8-5C96835FBFE3Q36641639-C6CAEA7C-3D52-4571-A10B-4A05A808E8E3Q37332277-5529D8C8-793B-4BDD-B23E-5207259B7417Q37340906-683B6818-4864-47A0-9244-78912A4B4DD2Q37838793-FA513B84-4645-4249-A9FE-FB2CFAA07682Q38018981-EA32E63E-6F01-4C0B-88FF-5ED5B9FF0483Q38350416-0F42DF45-A008-4E1F-8F9C-2368416F0147Q38529649-0FE3378C-E0DA-42E2-9FE0-231428FB3A02Q39216631-60A9859A-6383-4B7C-9824-02C056694CF5Q39855368-9EA1AC05-DCC1-4961-9AD2-85F201170C2DQ40573089-56D70292-874F-4879-8BBB-C8B55F0FC87BQ42983668-5270DB6E-542E-47A5-B3BC-30014662786CQ42993374-C6BB840B-2D82-42CA-A44C-7EDACF265CADQ43035307-99D23EF2-DD9F-4731-AF44-21433B7CF42AQ43039176-0F424871-66AC-4777-931D-48B1E15C27A7
P2860
Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@ast
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@en
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@nl
type
label
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@ast
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@en
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@nl
prefLabel
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@ast
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@en
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@nl
P2093
P2860
P1433
P1476
Full-length GB virus C (Hepati ...... n primary CD4-positive T cells
@en
P2093
P2860
P304
P356
10.1128/JVI.74.19.9125-9133.2000
P577
2000-10-01T00:00:00Z